Clinical Type 2 Diabetes Review: Intensification Beyond First-lineTherapy - Certificate of Completion

Duration

N/A

Profession

Allied Health

Nursing

Pharmacy

# of Credits

0.25

Accreditation

Certificate of Completion

Expiry Date

2020-05-13

In this program, we review a patient case to understand the intensification of therapy beyond metformin

This program is estimated at 0.25 hour(s) of interactive online continuing health education.

David C.W. Lau(MD, PhD, FRCPC),
David Strain(MB, ChB, BSc (Hons) MD, FRCP),
Deanna Telner(MD, CCFP),
Elizabeth Rosolowsky(MD, MPH, FAAP, FRCPC),
Filip K. Knop(MD, PhD),
Jeffrey Habert(MD, CCFP, FCFP),
John Axler(MD, CCFP, FCFP),
Peter J. Lin(MD, CCFP),
Robyn L. Houlden(MD, FRCPC),
Thomas Round(MBBS, BSc, DRCOG, MRCGP)

Upon completion of this program, participants will be able to:

  1. Review the key considerations for selecting an antihyperglycemic agent after metformin therapy
  2. Examine the impact of cardiovascular disease and patient preference on antihyperglycemic agent selection


Related Courses